Jaguar Health Return on Equity

Jaguar Health (JAGX) currently reports a ROE of -552.34%. That is below the Healthcare sector average of 20.77%. Use the charts on this page to explore Jaguar Health's ROE history and peer comparisons.

Jaguar Health's ROE of -552.34% is lower than the Healthcare sector average of 20.77%. That is roughly 2759.8% below the sector mean. A reading lower peers can reflect different growth expectations, capital structure, or profitability — so it is worth checking the peer comparison chart before drawing conclusions.

There is no universal 'good' ROE, but Jaguar Health's current -552.34% should be judged against Healthcare norms (sector average: 20.77%) and against JAGX's own history. Strong, stable readings often indicate durable competitive advantage; volatile or declining ones deserve a closer look at margins and capital efficiency.

Start with the current ROE of -552.34%, then check the historical chart for trend and the peer comparison chart for relative positioning. The Healthcare average is 20.77%. From there, open related valuation or income-statement pages for Jaguar Health, and consider following JAGX for alerts when major investors trade the stock.

Jaguar Health is classified in the Healthcare sector. On ROE, it currently shows -552.34% versus a sector average near 20.77%. Sector peers often share similar capital intensity and growth regimes, so relative rankings inside Healthcare are usually more informative than comparing JAGX with unrelated industries.